ArticlePharmaceuticals (Basel, Switzerland)2024

Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway.

Yazmín K Márquez-Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.